Latest Breaking News On - ஜூடி மேத்யூஸ் - Page 1 : comparemela.com

Iterum Therapeutics plc Announces $35.0 Million Registered Direct Offering of Ordinary Shares Priced At-the-Market under Nasdaq Rules February 09, 2021 23:58 ET | Source: Iterum Therapeutics plc Iterum Therapeutics plc Dublin 2, IRELAND DUBLIN, Ireland and CHICAGO, Feb. 09, 2021 (GLOBE NEWSWIRE) Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that it has entered into definitive agreements with several healthcare-focused institutional investors for the purchase and sale of 17,500,000 of its ordinary shares at a purchase price of $2.00 per ordinary share in a registered direct offering priced at-the-market under Nasdaq rules. The offering is expected to close on or about February 12, 2021, subject to the s

New yorkUnited statesJudy matthewsExchange commissionHc wainwright coNew drug applicationIterum therapeuticsQualified infectious disease productFast trackNasdaq capital marketQuarterly reportNasdaq itrmIterum therapeutics plcபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்ஜூடி மேத்யூஸ்